Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Total Debt (2023 - 2025)

AVITA Medical (RCEL) has disclosed Total Debt for 3 consecutive years, with $43.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt rose 1.75% year-over-year to $43.0 million, compared with a TTM value of $43.0 million through Dec 2025, up 1.75%, and an annual FY2025 reading of $43.0 million, up 1.75% over the prior year.
  • Total Debt was $43.0 million for Q4 2025 at AVITA Medical, up from $3.0 million in the prior quarter.
  • Across five years, Total Debt topped out at $45.2 million in Q2 2025 and bottomed at $3.0 million in Q3 2025.
  • Average Total Debt over 3 years is $38.1 million, with a median of $42.2 million recorded in 2024.
  • Peak annual rise in Total Debt hit 10.31% in 2025, while the deepest fall reached 92.95% in 2025.
  • Year by year, Total Debt stood at $39.8 million in 2023, then grew by 6.11% to $42.2 million in 2024, then grew by 1.75% to $43.0 million in 2025.
  • Business Quant data shows Total Debt for RCEL at $43.0 million in Q4 2025, $3.0 million in Q3 2025, and $45.2 million in Q2 2025.